First Citizens Bank & Trust’s Vertex Pharmaceuticals VRTX Stock Holding History

First Citizens Bank & Trust’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$714K	Sell	1,603 -2,594	-62%	-$1.15M	0.01%	343
2025 Q1	$2.03M	Sell	4,197 -639	-13%	-$310K	0.05%	188
2024 Q4	$1.95M	Sell	4,836 -21,153	-81%	-$8.52M	0.04%	185
2024 Q3	$12.1M	Sell	25,989 -1,410	-5%	-$656K	0.27%	56
2024 Q2	$12.8M	Sell	27,399 -411	-1%	-$193K	0.24%	53
2024 Q1	$11.6M	Buy	27,810 +6,414	+30%	+$2.68M	0.22%	55
2023 Q4	$8.71M	Sell	21,396 -647	-3%	-$263K	0.16%	59
2023 Q3	$7.67M	Sell	22,043 -3,761	-15%	-$1.31M	0.15%	58
2023 Q2	$9.08M	Buy	25,804 +5,908	+30%	+$2.08M	0.17%	57
2023 Q1	$6.27M	Buy	19,896 +8,602	+76%	+$2.71M	0.13%	67
2022 Q4	$3.26M	Sell	11,294 -80	-0.7%	-$23.1K	0.1%	82
2022 Q3	$3.29M	Sell	11,374 -2,619	-19%	-$758K	0.11%	86
2022 Q2	$3.94M	Buy	13,993 +543	+4%	+$153K	0.14%	75
2022 Q1	$3.51M	Buy	13,450 +483	+4%	+$126K	0.14%	94
2021 Q4	$2.85M	Buy	12,967 +164	+1%	+$36K	0.11%	107
2021 Q3	$2.32M	Sell	12,803 -1,165	-8%	-$211K	0.11%	110
2021 Q2	$2.82M	Sell	13,968 -751	-5%	-$151K	0.13%	99
2021 Q1	$3.16M	Buy	14,719 +269	+2%	+$57.8K	0.15%	95
2020 Q4	$3.42M	Sell	14,450 -484	-3%	-$114K	0.17%	86
2020 Q3	$4.06M	Buy	14,934 +1,598	+12%	+$435K	0.29%	65
2020 Q2	$3.87M	Buy	13,336 +4,706	+55%	+$1.37M	0.32%	75
2020 Q1	$2.05M	Buy	8,630 +5,518	+177%	+$1.31M	0.25%	93
2019 Q4	$681K	Buy	+3,112	New	+$681K	0.07%	196
2019 Q2	–	Sell	-5,442	Closed	-$1M	–	441
2019 Q1	$1M	Buy	5,442 +570	+12%	+$105K	0.11%	180
2018 Q4	$807K	Buy	+4,872	New	+$807K	0.1%	192
2018 Q2	–	Sell	-4,798	Closed	-$782K	–	458
2018 Q1	$782K	Buy	+4,798	New	+$782K	0.11%	196
2017 Q4	–	Sell	-2,720	Closed	-$414K	–	432
2017 Q3	$414K	Buy	+2,720	New	+$414K	0.05%	245
2013 Q4	–	Sell	-21,926	Closed	-$1.66M	–	791
2013 Q3	$1.66M	Buy	21,926 +2,456	+13%	+$186K	0.06%	277
2013 Q2	$1.56M	Buy	+19,470	New	+$1.56M	0.06%	278